Back to search

Article

Integrated UPLC-MS/MS Metabolomics Reveals Novel Metabolic Markers for Type I Endometrial Carcinogenesis in Clinical Samples

2026-07-14

Abstract excerpt

<title>Abstract</title> <p> Objective This study aimed to identify differential metabolites between type I endometrial cancer (EC) and normal tissues (NT) using untargeted metabolomics based on ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). We further explored key metabolites and metabolic pathways to underpin clinical diagnosis and treatment. Methods Paired cancerous and normal...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8bc56961-75d5-5a3a-914a-1a7159e6124d
DOI
10.21203/rs.3.rs-9963643/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Integrated UPLC-MS/MS Metabolomics Reveals Novel Metabolic Markers for Type I Endometrial Carcinogenesis in Clinical SamplesDOI 10.21203/rs.3.rs-9963643/v1
Select a neighboring publication to make it the new centre.